QVAR®

INHALED CORTICOSTEROIDS

INHALED CORTICOSTEROID (ICS)

  • Class

    • Inhaled corticosteroid (ICS)

  • Active ingredient

    • Beclomethasone dipropionate

  • Device

  • Age

    • 5 +
  • Typical use

    • Asthma
      Initial controller

    Asthma management principles
    • COPD (off-label)
      in addition to a dual bronchodilation (LAMA/LABA) when exacerbating

    COPD management principles
  • Marketed strength

    • 50 mcg
    • 100 mcg
  • Number of doses

    • 200 doses
  • Dose indicator

    • No
  • Usual adult dosage

    • Low | 100 mcg – 1 inh BID
      Medium | 100 mcg – 2 inh BID
      High | 100 mcg – 3-4 inh BID
      Maximum daily dose:  800 mcg

    ICS dosing
  • Usual pediatric dosage

    • 5-11 years
      Low
      | 100 mcg – 1 inh QD
      Medium | 100 mcg – 1 inh BID

      12-17 years
      See adult dosage

    ICS dosing
  • Required inspiratory flow

    • < 30 L/min 
      Zero internal resistance (R0)

    Inspiratory flows
  • Public coverage

    • All provinces | Open/Regular Benefit

  • Advantages

    • Suitable for low inspiratory flows
    • No synchronism required with a spacer
  • Disadvantages

    • BID dosing
    • Cumbersome with a spacer
    • Impossible to know when empty
    • Round mouthpiece may be difficult to insert in a spacer
    • Contain greenhouse gases
    Side effects

Product monograph

Download

Search for other inhalers